Skip to main content
Premium Trial:

Request an Annual Quote

Tm Bioscience to Supply LabCorp with Tag-It Reagents for Cystic Fibrosis Assay

NEW YORK, Oct. 13 (GenomeWeb News) - Toronto-based Tm Bioscience has penned a supply deal with Laboratory Corporation under which Tm will provide Tag-It CF70 reagent for use in the clinical reference lab giant's cystic fibrosis assay, the companies said today in a statement.


Under a master purchase agreement the companies announced in June, Tm agreed to provide "a suite of Tag-It products" for LabCorp's genetic assays. The first of these reagents involved Ashkenazi Jewish Panel gene assay. Tm signed a similar agreement with Quest Diagnostics in May.


Tm Bioscience's Tag-It assays use a proprietary tag system and operate on a Luminex xMap bead-based array system.


The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.